148 related articles for article (PubMed ID: 11866538)
1. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex.
Tsiamis AC; Morris PN; Marron MB; Brindle NP
Microvasc Res; 2002 Mar; 63(2):149-58. PubMed ID: 11866538
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of metalloprotease mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1.
McCarthy MJ; Burrows R; Bell SC; Christie G; Bell PR; Brindle NP
Lab Invest; 1999 Jul; 79(7):889-95. PubMed ID: 10418829
[TBL] [Abstract][Full Text] [Related]
3. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases.
Singh H; Milner CS; Aguilar Hernandez MM; Patel N; Brindle NP
Cell Signal; 2009 Aug; 21(8):1346-50. PubMed ID: 19376222
[TBL] [Abstract][Full Text] [Related]
5. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
6. VEGF receptor signaling and endothelial function.
Kliche S; Waltenberger J
IUBMB Life; 2001 Jul; 52(1-2):61-6. PubMed ID: 11795595
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
8. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion.
Lin TN; Nian GM; Chen SF; Cheung WM; Chang C; Lin WC; Hsu CY
J Cereb Blood Flow Metab; 2001 Jun; 21(6):690-701. PubMed ID: 11488538
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of vascular endothelial growth factor, relative receptors and ligands in vascular endothelial cells of cerebral arteriovenous malformation].
Li J; Gao Y; Zhao M
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):675-8. PubMed ID: 11769600
[TBL] [Abstract][Full Text] [Related]
10. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
Wang D; Lehman RE; Donner DB; Matli MR; Warren RS; Welton ML
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G1088-96. PubMed ID: 12016135
[TBL] [Abstract][Full Text] [Related]
11. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells.
Chen JH; Wang XC; Kan M; Sato JD
Cell Biol Int; 2001; 25(3):257-60. PubMed ID: 11352499
[TBL] [Abstract][Full Text] [Related]
12. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
14. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
15. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
Gerber HP; Malik AK; Solar GP; Sherman D; Liang XH; Meng G; Hong K; Marsters JC; Ferrara N
Nature; 2002 Jun; 417(6892):954-8. PubMed ID: 12087404
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of human thyroid endothelial cells.
Patel VA; Logan A; Watkinson JC; Uz-Zaman S; Sheppard MC; Ramsden JD; Eggo MC
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E168-76. PubMed ID: 12388152
[TBL] [Abstract][Full Text] [Related]
17. VEGF receptor signal transduction.
Matsumoto T; Claesson-Welsh L
Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
19. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
20. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]